Daily Stock List
Enerpulse Technologies, Inc. (ENPT)
OTC Markets Group reported earlier on Enerpulse Technologies, Inc. (ENPT), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.
Established in 2004, Enerpulse Technologies, Inc. develops and manufactures ultra-high performance, low emissions ignition products via the application of pulse power technology. Through its wholly-owned subsidiary, Enerpulse, Inc., it designs, develops, manufactures, and markets an energy and efficiency enhancing product in the automotive industry under the Pulstar® brand name. Enerpulse Technologies has its corporate headquarters in Albuquerque, New Mexico.
The Company provides products to three markets: Automotive original equipment manufacturers (OEMs); NatGas Fueled SI Engines (NG, CNG, LNG, LPG, Bio-Gas) – Stationary & Vehicular Applications; and the Automotive/Power Sports Aftermarket under the brand name Pulstar®. Pulstar® with PlasmaCore Pulse Plug uses an integrated capacitor, which stores and compresses electrical energy to intensify the ignition spark in internal combustion engines (ICE). The process increases fuel economy and engine performance. Pulse plugs feature a unique capacitor-based circuit.
This circuit captures energy normally wasted by spark plugs and produces a spark with 20,000 times greater energy than any spark plug. Electrical energy from the engine’s ignition coil is stored in the built-in capacitor. At the exact moment needed, that energy is released in a powerful and fast (two nanosecond) high-energy pulse.
Pulstar® with PlasmaCore spark plug is made with the Company’s patented Nano-Plasma Assisted Combustion (n-PAC®) technology. This technology intensifies the ignition spark. This increases fuel economy, reduces tailpipe emissions, as well as improves engine performance. Enerpulse Technologies’ Pulstar® with PlasmaCore aftermarket products can be used in all spark-ignited IC engines. This includes passenger cars, light trucks, commercial trucks, and motorcycles. The Company’s Pulstar® with PlasmaCore pulse plugs fit directly into existing IC engine ignition systems and use existing fuel delivery infrastructures.
Recently, Enerpulse Technologies announced that it has started development of its C2 ignition system financed in part by a $749,868 grant awarded by the California Energy Commission (CEC) with Enerpulse Technologies named as prime-subcontractor. As stated by the CEC "ignition characteristics of natural gas fuel represent challenges to engine manufacturers working to satisfy tighter emission standards, achieve lower fuel consumption and higher engine performance." The CEC's stated objective is to "advance the functionality of natural gas ignition under high boost pressure and heavy EGR conditions to facilitate the development of engines with lower nitrogen oxides (NOx) and greenhouse gas (GHG) emissions."
Enerpulse Technologies, Inc. (ENPT), closed Friday's trading session at $0.10, even for the day, on 550 volume with 2 trades. The average volume for the last 60 days is 5,687 and the stock's 52-week low/high is $0.04/$0.50.
OXIS International, Inc. (OXIS)
Cannabis Financial Network News, TopPennyStockMovers, Gryphon Digest, and PennyStocks24 reported earlier on OXIS International, Inc. (OXIS), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
OXIS International, Inc. is a developer of unique drugs centered on the treatment of cancer and other unmet medical needs. The Company’s lead drug candidate, OXS-2175, is a small molecule therapeutic candidate targeting the treatment of triple-negative breast cancer (TNBC). In in vitro and in vivo models of TNBC, OXS-2175 demonstrated the ability to inhibit metastasis. OXIS is targeting multiple myeloma, triple-negative breast cancer, non-Hodgkin's lymphoma and more with highly potent biopharmaceutical drugs designed for targeted therapy.
OXIS International is headquartered in Tampa, Florida. Oxis Biotech, Inc. is a wholly-owned subsidiary of Oxis International.
The Company’s other lead drug candidate, DT2219ARL, is a novel bispecific scFv recombinant fusion protein-drug conjugate. It consists of the variable regions of the heavy and light chains of anti-CD19 and anti-CD22 antibodies and a modified form of diphtheria toxin as its cytotoxic drug payload.
DT2219ARL at the same time targets cancer cells expressing the CD19 receptor or CD22 receptor or both receptors. When DT2219ARL binds to cancer cells, the cancer cells internalize DT2219ARL and are killed because of the action of drug's cytotoxic payload. DT2219ARL has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia.
The Company’s OXS-4235 is a small molecule therapeutic candidate. It targets the treatment of multiple myeloma and associated osteolytic lesions. In in vitro and in vivo models of multiple myeloma and osteoporosis, OXS-4235 demonstrated the ability to kill multiple myeloma cells, and lessen osteolytic lesions in bone.
In September 2015, Oxis Biotech announced the execution of an exclusive global license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.
Mr. Anthony J. Cataldo, Chairman and Chief Executive Officer of Oxis Biotech, said in September, “We are pleased to have the opportunity to further develop DT2219ARL. There were several other major companies interested in acquiring this technology and we are honored to be the partner selected for this.”
OXIS International, Inc. (OXIS), closed Friday's trading session at $0.013, up 11.11%, on 1,162,791 volume with 32 trades. The average volume for the last 60 days is 1,999,925 and the stock's 52-week low/high is $0.0107/$0.07.
Falconridge Oil Technologies Corp. (FROT)
The Bull Report, Wall Street Wolves, PremiereStockAlerts, MyBestStockAlerts, and Smart Penny Stocks reported previously on Falconridge Oil Technologies Corp. (FROT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Falconridge Oil Technologies Corp. is a developing oil and gas technology enterprise listed on the OTCQB. The Company centers on licensing, developing, and deploying unique technologies to enable operators to economically increase production levels, expand known oil and gas reserves, and reduce environmental impact. Falconridge provides operators a lower-cost option to drilling a new well. The Company is headquartered in Richmond Hill, Ontario.
Falconridge Oil Technologies’ goal is to shift the industry and social paradigm away from new drilling and towards increasing efficiency of current extraction in existing well-bores to increase recovery of oil and gas. Its licensed and patented third-generation Terra Slicing Technology™ (TST™) is an option as an alternative to traditional fracturing/fracking on existing low producing wells throughout the United States and Canada. Terra Slicing is an advanced proprietary excavation and hydro cutting technology.
TST is applied to producing well assets, dead wells, non-performing well assets, and low yield assets. TST utilizes patented oil and gas completion technology to increase the production of under-performing oil and gas assets by way of precision excavation and cutting of damaged productive hydrocarbon zones. This increases permeability, creates previously non-existent vertical permeability, increases the overall drainage area of the well, and avoids further damage caused by explosive charge perforation. TST is used to enhance "dead" or non-performing well assets. This essentially revitalizes the per-existing well and establishes a flow rate with a significant percentage of its initial production.
Additionally, the Company has its Terra-Seal™. This is a patented abrasive jet cutting completion process to cut smoothly through casing with high-pressure slurry (up to four or more casings). The design of Terra-Seal™ is to excavate vertical windows in the cement and deep into near well-bore rock in two 180o-phased directions (up to 4 sets). The Terra-Seal™ machine is the only down-hole tool, which can be per-programmed to control itself at down-hole point of engagement and not at surface.
Falconridge Oil Technologies Corp. (FROT), closed Friday's trading session at $0.0003, down 25.00%, on 15,642,988 volume with 27 trades. The average volume for the last 60 days is 5,499,939 and the stock's 52-week low/high is $0.0004/$1.32.
Arch Therapeutics, Inc. (ARTH)
Wall Street Resources, RedChip, and PennyStocks24 reported on Arch Therapeutics, Inc. (ARTH), and we choose to highlight the Company as well, here at the QualityStocks Daily Newsletter.
Wellesley, Massachusetts-based Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Its objective is to develop and commercialize products based on its pioneering technology platform. This platform makes surgery and interventional care faster and safer for patients. The underlying technology, exclusively licensed from a top university, supports a leading-edge platform of smart materials that fulfill the criteria as a solution for a specialized field the Company calls, “stasis and barrier applications.” Arch Therapeutics lists on the OTC Bulletin Board.
The Company’s flagship development stage product candidate is called AC5™ (AC5 Surgical Hemostatic Device™). This is a synthetic peptide consisting of naturally occurring amino acids. AC5™ is undergoing design to smoothly attain hemostasis in minimally invasive (laparoscopic) and open surgical procedures. Its solution smartly controls the movement of fluids and substances. AC5™ stops bleeding quickly. AC5™ conforms to irregular wound geometry and assists in maintaining a clear field of vision directly into the wound area.
AC5™, when squirted or sprayed onto a wound, rapidly intercalates into the nooks and crannies of the connective tissue where it builds itself into a physical, mechanical structure. That structure provides a barrier to leaking substances (including blood and other bodily fluids) regardless of type of surgery or, based on early data, clotting ability, and healing occurs normally. Arch Therapeutics indicates that in preclinical tests, AC5™ has been simple, effective, and versatile.
Arch Therapeutics announced this past June that it executed a collaboration agreement with CÚRAM Centre for Research in Medical Devices. CÚRAM is a new center of excellence for research headquartered in Galway, Ireland. It aims to radically improve health outcomes for patients through developing and collaborating on the development of "smart" medical devices.
Arch Therapeutics has obtained data from a preclinical toxicity test for AC5™ that show the device was well-tolerated and classified as "not toxic" in a standardized test of systemic toxicity. The systemic toxicity animal test is a major component of the biocompatibility test panel that a medical device must typically complete successfully before use in human beings.
In September of this year, Arch Therapeutics announced that it obtained favorable data from a preclinical toxicology test for AC5™ showing that the device did not cause sensitizing reactions in animals and is considered a "non-sensitizer." The test (the Maximization Test) is a standardized test of contact sensitization.
Arch Therapeutics, Inc. (ARTH), closed Friday's trading session at $0.1985, even for the day, on 152,032 volume with 33 trades. The average volume for the last 60 days is 463,673 and the stock's 52-week low/high is $0.17/$0.391.
LabStyle Innovations Corp. (DRIO)
Stock News Now, SmallCapVoice and TopPennyStockMovers reported earlier on LabStyle Innovations Corp. (DRIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Israel-based LabStyle Innovations Corp. is the developer of Dario™, a cloud-based, mobile health platform for diabetes and blood glucose monitoring. The Company is a mobile health (mHealth) enterprise developing and commercializing patent-pending technology providing consumers with laboratory-testing capabilities using smart mobile devices. The Company formed with a mission to advance the way consumers engage, monitor, and lead healthier lives via the commercialization of innovative, self-diagnostic technologies and platforms. LabStyle Innovations lists on the OTC Markets Group’s OTCQB.
The Company’s flagship product is the Dario™ Diabetes Management Solution. Dario™ received CE mark certification in September of 2013. LabStyle Innovations is pursuing patent applications in a number of areas covering the specific processes related to blood glucose level measurement and more general methods of rapid tests of body fluids using mobile devices and cloud-based services.
The Dario™ diabetes management platform includes the novel Dario™ app, website software, and an 'all-in-one', pocket-sized, Dario™ blood glucose monitoring device that comes complete with lancet, strips and a glucose meter. The glucose meter connects to a smartphone and the feature rich Dario™ mobile and website applications. This enables patients, medical professionals, and caregivers to access and analyze data in real time and from histories.
LabStyle Innovations has released the Dario™ Diabetes Management App for Android smartphone users. The mobile application has the same user interface and features as the iOS Dario™ Application. The Dario mobile app is a complete, cloud-based solution for personal diabetes management. It gives an individual and their support network real-time tools and actionable information. Thus, this makes it easy for a person to track and better understand their glucose levels.
LabStyle Innovations has started the worldwide launch of its Dario Diabetes Management System. The U.S. Patent and Trademark Office (USPTO) granted the Company a patent covering core functions of the Dario™. LabStyle Innovations recorded its first revenues in Q4 2014 from sales of Dario™.
Recently, LabStyle Innovations announced results from a recent performance accuracy study of the Dario™ Blood Glucose Monitoring System. Data was presented by Dr. Paul Rosman at the 15th Annual Diabetes Technology Meeting in Bethesda, Maryland which took place on October 22-23, 2015. Dr. Rosman serves on LabStyle Innovations’ Scientific Advisory Board. The poster is titled "Performance of a Smart Phone Linked Blood Glucose Assessment Platform." It presented data that showed the Dario™ meets new International Standards Organization (ISO) 2013 performance requirements for accuracy and with excellent precision results.
LabStyle Innovations Corp. (DRIO), closed Friday's trading session at $0.387, up 1.84%, on 108,272 volume with 37 trades. The average volume for the last 60 days is 69,184 and the stock's 52-week low/high is $0.12/$0.53.
GTX Corp. (GTXO)
The QualityStocks Daily Newsletter would like to spotlight GTX Corp. (GTXO). Today, GTX Corp. closed trading at $0.0119, up 13.33%, on 1,091,000 volume with 10 trades. The stock’s average daily volume over the past 60 days is 644,372, and its 52-week low/high is $0.0058/$0.023.
GTX Corp. (GTXO), through its robust IoT enterprise monitoring platform and licensing, subscription recurring revenue business model, offers a complete end-to-end solution backed by an extensive portfolio of patents with filing dates going back as early as 2002, patents pending, registered trademarks, copy rights and URLs. GTX was featured in a 38-page research piece outlining the value proposition of the company's IP portfolio, and was also published in a SeeThruEquity research report discussing the value of the company's IP.
GTX has established a growing global distribution network with partners in more than 20 countries, and has garnered millions of dollars' worth of free media with coverage on CNN, Good Morning America, The Doctors, Fox News, Discovery Channel, ABC, NBC, CBS, The New York Times, LA Times, U.S.A. Today, the LA Business Journal, AARP and hundreds of other television, radio, magazine and newspaper media outlets across the globe.
The company's flagship, patented GPS SmartSoles were recently showcased in Munich at the Telefonica Digital Innovation Day 2015; was featured in AARP's 2015 technology gear guide; and came in second place, with Microsoft finishing first and Samsung taking third, in the 2015 Wearables, Health, Fitness & Wellness category at CTIA's Hot for the Holidays Awards competition.
As GTX continues to expand its brand awareness and distribution channels both domestically and internationally, in parallel it also plans to introduce new products with an emphasis on e-health and wellness. Corporate strategies are guided by a visionary management team with the insight and experience needed to navigate the plentiful opportunities and potential market share in the emerging multibillion IoT and Wearable Tech industries.
"With approximately 2% of the population having been diagnosed with Alzheimer's, dementia, autism, TBI or some other cognitive disorder which may lead to wandering due to memory loss, GTX plays a vital role in the safety, security and recovery of these individuals and their caregivers." --- Patrick Bertagna GTX Corp CEO. Disclaimer
GTX Corp. Company Blog
GTX Corp. News:
GTX Corp Reports Third Quarter 2015 Financial Results and Business Overview
GTX Corp (GTXO) Announces Engagement of QualityStocks Investor Relations Services
Denmark Launches GPS SmartSoles
Star Mountain Resources, Inc. (SMRS)
The QualityStocks Daily Newsletter would like to spotlight Star Mountain Resources, Inc. (SMRS). Today, Star Mountain Resources, Inc. closed trading at $0.935, up 14.02%, on 3,500 volume with 5 trades. The stock’s average daily volume over the past 60 days is 6,475, and its 52-week low/high is $0.50/$1.40.
Star Mountain Resources, Inc. (SMRS), a minerals exploration company, is focused on acquiring and consolidating mining claims, mineral leases, producing mines, and historic mines with production and future growth potential identified through exploration efforts. The company's operations are currently focused on the initiation, production and expansion of acquired mineral resources in the Star Mountain Mining District, Beaver County, Utah and turning them into producing assets.
Comprised of 2,320 acres, the company's Star Mountain/Chopar Mine project consists of 116 lode-mining claims and four metalliferous mineral lease sections located in the Star Mountain range, Star Mining District, in Beaver County, Utah, approximately five miles west of Milford, Utah. Exploration activities to date include geological analysis, and a limited reverse circulation & core drilling program.
The Star Mountain Mining District, which is dotted with historic mines dating back to the late 1800s, has a long and storied history within the mining industry. The company believes that the application of modern exploration tools will reveal additional resources that were previously unattainable. Leveraging the region's mild climate and accessibility to nearby rail lines and roads, management will look to translate this potential into sustainable returns in the years to come.
Star Mountain Resources has adopted a discovery-based business model to grow its industry presence in the future. The company plans to thoroughly explore and initially develop its leasehold before seeking senior industry partners to assist in the capital-intensive development and operation phases. Building on this strategy, Star Mountain Resources will also continue to seek quality projects that can be evaluated on their own technical and financial merit. Disclaimer
Star Mountain Resources, Inc. Company Blog
Star Mountain Resources, Inc. News:
Star Mountain Resources, Inc. Closes Acquisition of Balmat Zinc Mine in New York State
Star Mountain Resources, Inc. to Acquire Balmat Zinc Mine in New York State
Star Mountain Resources Inc. (SMRS) Pursues Acquisition Opportunities in North American Mining Sector
OurPet's Company (OPCO)
The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $1.00, up 3.09%, on 15,341 volume with 23 trades. The stock’s average daily volume over the past 60 days is 4,930, and its 52-week low/high is $0.45/$0.97.
OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.
In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.
The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.
OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer
OurPet's Company Company Blog
OurPet's Company News:
OurPet's Company (OPCO) Named 'Company of the Month' in November Issue of The Bowser Report
OurPet's Company Reports Q3 2015 Results, Including Record Net Revenue of Nearly $6.0 Million -- Net Income Up 428% to $410,450
MissionIR Exclusive Audio Interview With OurPet's Company (OPCO) Executive Management
Moxian, Inc. (MOXC)
The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXC). Today, Moxian, Inc. closed trading at $5.00, off by 1.96%, on 600 volume with 3 trades. The stock’s average daily volume over the past 60 days is 681, and its 52-week low/high is $5.00/$6.50.
Moxian, Inc. (MOXC) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.
Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."
Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.
Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.
Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer
Moxian, Inc. Company Blog
Moxian, Inc. News:
Moxian, Inc. (MOXC) Announces Engagement of DreamTeamNetwork Corporate Communications Service Suite
Moxian Announces China New Media Integrated Development Conference Sponsorship Agreement Has Changed
Moxian Enters Into US$8.19 Million Private Placement With Beijing Xinhua Huifeng Equity Investment Centre
WRIT Media Group, Inc. (WRIT)
The QualityStocks Daily Newsletter would like to spotlight WRIT Media Group, Inc. (WRIT). Today, WRIT Media Group, Inc. closed trading at $0.51, even for the day, on 2 volume with 2 trades. The stock’s average daily volume over the past 60 days is 876, and its 52-week low/high is $0.20/$6.00.
WRIT Media Group, Inc. (WRIT) is focused on expanding in the digital media industry. The holding company currently operates under two different divisions: content creation via Front Row Networks, and "retro" video gaming via Retro Infinity Inc. and Amiga Games Inc.
The company’s Front Row Networks subsidiary produces, acquires and distributes live concerts in 2D and 3D format for initial worldwide digital broadcast into digitally-enabled movie theaters. In addition to presenting live concerts to massive audiences at lower ticket prices, Front Row Networks will license the content for many different distribution channels and sell merchandize where the live concerts are exhibited. The subsidiary also secures and distributes non-concert alternative theatrical programming and aims to acquire the broadest range of rights for exclusive programming.
Retro Infinity specializes in licensing classic computer and console video game libraries and adapts and republishes the most popular titles for smartphones, modern game consoles, micro-consoles, PCs, and tablets. The company leverages platform and classic game brands, coupled with proprietary technologies, to create new revenue from dormant game libraries.
Amiga Games Inc. shares resources with Retro Infinity to adapt and republish the most popular titles from the Amiga family of computers for smartphones, modern game consoles, micro-consoles, PCs, and tablets. WRIT Media Group leverages the Amiga brand along with game brands of the past and proprietary technologies to create new revenue from classic games that have proven their ability to sell very well.
Together with its subsidiaries, WRIT Media Group is well positioned to benefit from the market growth and increased demand for alternative theatrical, mobile, and interactive content. Disclaimer
WRIT Media Group, Inc. Company Blog
WRIT Media Group, Inc. News:
Retro Infinity Kickstarter Campaign to Open an Awesome, Innovative Way to Play Classic Video Games
WRIT Media Group to Debut Retro Gaming Technology for Mobile Devices
WRIT Media Group Featured in Exclusive QualityStocks Production Video
Today's Top 3
INO.com Market Report
Epic Stock Picks
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Alternet Systems, Inc. (ALYI) CEO Featured in Exclusive QualityStocks Interview
- Avant Diagnostics, Inc. (AVDX) Receives FDA IRB Approval for OvaDx(R) Ovarian Cancer Validation Test Specimens
- Cherubim Interests, Inc. (CHIT) and Major Debt Holders Agree to Convert to Preferred Stock
- Dominovas Energy Corp. (DNRG) Signs Financing Agreement With GHS Capital
- Elephant Talk Communications Corp. (ETAK) Announces the Appointment of Robert H. Turner as Executive Chairman; Names ETNA President Tim Payne as Interim CEO
- Freedom Leaf Inc. (FRLF) Announces Engagement of QualityStocks Investor Relations Services
- Giggles N' Hugs, Inc. (GIGL) Westfield Seeks To Expand Partnership
- GTX Corp. (GTXO) Reports Third Quarter 2015 Financial Results and Business Overview
- Hemp, Inc. (HEMP) U.S. Hemp Fiber Sale Agreement Announced
- International Stem Cell Corp. (ISCO) Announces Operating Results for the Three- and Nine-Months Ended September 30, 2015
- Latitude 360, Inc. (LATX) Multi-Dimensional Entertainment Eatery Enhances Guest Experience and Engagement Through Partnership With MyCheck
- Legacy Ventures International, Inc. (LGYV) Award-Winning Actor, Screenwriter, Director, Producer and Jazz Vocalist, Robert Davi, Joins Legacy Ventures
- Lingo Media Corp. (LMDCF) to Present at the Small-Cap Conference on November 10th
- Moxian, Inc. (MOXC) Announces Engagement of DreamTeamNetwork Corporate Communications Service Suite
- Oakridge Global Energy Solutions, Inc. (OGES) to Be Showcased In Upcoming “New To The Street” Series
- OurPet's Company (OPCO) Named 'Company of the Month' in November Issue of The Bowser Report
- Star Mountain Resources Inc. (SMRS) Closes Acquisition of Balmat Zinc Mine in New York State
- WRIT Media Group, Inc. (WRIT) Retro Infinity Kickstarter Campaign to Open an Awesome, Innovative Way to Play Classic Video Games